Cardiovascular Business
@CardioBusiness
Followers
9K
Following
515
Media
417
Statuses
20K
Strategies in Economics, Practice and Technology. Subscribe to our newsletter: https://t.co/QCXV59be0I
United States
Joined August 2009
Boston Scientific launches study comparing drug-coated balloons to standard care . #PCI #DCB #Interventionalcardiology #Cathlab.
cardiovascularbusiness.com
"This important study will evaluate the potential benefits of the AGENT DCB for patients with certain anatomical features in de novo coronary lesions, where the avoidance of stents is preferable to...
0
0
0
"Eko is transforming how we detect cardiovascular disease—making cutting-edge, AI-powered tools accessible to frontline providers," said former U.S. Surgeon General Jerome Adams, MD. #Cardiology #HealthAI #Stethoscope #MedTwitter #Eko
cardiovascularbusiness.com
"Eko is transforming how we detect cardiovascular disease—making cutting-edge, AI-powered tools accessible to frontline providers," said former U.S. Surgeon General Jerome Adams, MD.
0
0
0
Australia-based Artrya says its Salix Coronary Plaque module offers near real-time, point-of-care CCTA assessment. #YesCCT #CCTA #Cardiology #HealthAI #radiology
cardiovascularbusiness.com
Australia-based Artrya Limited says its AI-enabled Salix Coronary Plaque module offers near real-time, point-of-care CCTA assessment and management of coronary artery disease.
0
0
0
Video - Greg Piefer, PhD, CEO and founder, Shine, explains how the radiopharmaceutical company is building the world’s largest medical isotope production facility in Janesville, Wisconsin to supply molybdenum-99. #SPECT #Moly99 #CVNuc #NuclearMedicine
cardiovascularbusiness.com
Greg Piefer, PhD, chief executive and founder of Shine, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wiscons...
0
0
0
Cardiology leads the FDA Breakthrough Device designations with 218 devices, the highest number out of all other clinical categories. This includes 16 new devices cleared in the past year. #Cardiology #FDA #breakthroughdevice #breakthroughmedicine
cardiovascularbusiness.com
Cardiology is number one in FDA Breakthrough Device designations at 218, the highest number out of all other clinical categories. This includes 16 new devices cleared in the past year.
1
0
0
Edwards Lifesciences asked the FTC to dismiss the complaint against its acquisition of JenaValve, while a market analysis firm said the FTC action will likely impact FDA clearance of the Trilogy heart valve. #TAVR #PureAR #JenaValve #aorticregurgitation
cardiovascularbusiness.com
Edwards Lifesciences asked the U.S. Federal Trade Commission (FTC) this week to dismiss the complaint against the company's acquisition of JenaValve this week. A healthcare market analysis firm also...
1
0
0
FDA clears clinical trial of first-in-class treatment for pulmonary arterial hypertension #cardiology
cardiovascularbusiness.com
The new drug, VTB-10, previously received the FDA's orphan drug designation in 2024.
0
0
0
Video - Kenzie Thompson, BSN, RCIS, St. Luke's Mid-America Heart Institute, shares advice for cath lab technologists and nurses on how to be prepared for complications in the cath lab. #Cathlab #Interventionalcardiology #cardiology
cardiovascularbusiness.com
“It is your responsibility to be the patient’s advocate,” one expert explained. “We, as the nurses and technologists, have to speak up when we see something that isn’t right.”
0
0
1
#TAVR in patients with bicuspid aortic valve stenosis: Does device type matter? #cardiology #BAV #bicuspidaorticvalve
cardiovascularbusiness.com
More and more care teams are treating BAV stenosis with TAVR instead of surgical aortic valve replacement. Self-expanding and balloon-expandable valves appear to have their own benefits—as well as...
0
1
2
“Technological innovation has transformed how we treat premature infants with PDA, but technology alone is not enough,” said Sarosh “Shawn” P. Batlivala, MD. #PDAclosure #Congenitalheart #PDA #Pediatrics
cardiovascularbusiness.com
Transcatheter patent ductus arteriosus (PDA) closure has been a mainstay in congenital interventional cardiology for decades, but changes in the standard of care have resulted in catheter-based...
0
0
0
FDA shares details after insulin pump error linked to 700 adverse events #cardiology #diabetes
cardiovascularbusiness.com
Speaker issues are causing the devices to stop communicating with the user's CGM. Dozens of patient injuries have been reported, and the company is prepping a software update.
0
0
0
“Our findings reveal how changes in cell metabolism and increased oxidative stress can activate damaging pathways in blood vessels," explained Xiaofeng Yang, MD, Temple University. #Cardiology #CKM
cardiovascularbusiness.com
“Our findings reveal how changes in cell metabolism and increased oxidative stress can activate damaging pathways in blood vessels," explained Xiaofeng Yang, MD, a researcher at Temple University.
0
1
0
ICYMI: Medtech company raises $32M to expand research on foam-based #LAAO device #cardiology
cardiovascularbusiness.com
New Hampshire-based Conformal Medical plans on using the funds to enroll more patients into an ongoing clinical trial.
1
0
0
New #hypertension guidelines embrace early treatment, a new risk calculator and renal denervation @ACCinTouch @American_Heart @JACCjournals @RecorMedical @Medtronic #cardiology
cardiovascularbusiness.com
New ACC/AHA recommendations encourage clinicians to take a proactive approach when managing patients with elevated or high blood pressure. The inclusion of renal denervation in this document repres...
0
0
3
FDA shares new safety concern with Medtronic catheters—warns of possible shortage in months ahead #cardiology
cardiovascularbusiness.com
The FDA has received multiple reports of the devices, which are designed to be malleable, failing to retain their shape. The issue has been linked to three patient injuries so far, and customers are...
1
0
1
FDA announces Class I recalls for heart pump accessories due to safety risk #cardiology
cardiovascularbusiness.com
Abbott has warned healthcare providers about a new issue with the mobile power units of certain HeartMate 3 LVADs.
1
0
0
Video - he cardiology community may soon see a major shift in how it identifies and manages patients at risk for heart disease—and it’s coming from a particle many physicians have never tested for: Lipoprotein(a), or Lp(a). #cardiology #Lp(a) #LDL #ASPC
cardiovascularbusiness.com
"Lp(a) represents the most important potential potential paradigm shift in cardiovascular disease prevention that we'll experience over the next five to 10 years," Seth Baum, MD, explained in a new...
0
0
0